MEDICINE: System Is Betting On Treatment Strategies Success
UC San Diego Health has launched a Medicare program that brings the potential for health system savings — that is, if it can meet care and cost requirements.
San Diego-based Sempra Energy’s $9.45 billion acquisition of Texas energy giant Oncor appears headed for approval.
Carlsbad’s Ionis Pharmaceuticals has licensed a kidney drug to British giant AstraZeneca, earning $30 million upfront and the potential for $300 million in development and regulatory milestone payments.
Medical staffing company AMN Healthcare reported 2017 fourth quarter revenue of $509 million, a 4 percent year-over-year increase.
MANUFACTURING: Its Acquisitions Boost Core Biz, Help Cover New Ground
It’s not uncommon to see sprinklers over-irrigate, turning yards into swamps — or spraying water while it’s raining.
San Diego’s Tandem Diabetes Care inked a European distribution deal with Rubin Medical, meaning its insulin pumps will be sold outside the U.S. for the first time.
DEVICES: Company Gains Advantage By Partnering With Insurer
Dexcom aspires to widen its reach beyond Type 1 diabetes. Recently, the San Diego company took a big step toward the goal.
A first-ever test from San Diego’s Banyan Biomarkers to help doctors diagnose traumatic brain injuries has won Federal Drug Administration approval.
San Diego biotech Neurocrine reported a big increase in revenue following the launch of a nervous system drug in late spring, according to financial results released Feb. 13.
An Encinitas developer has struck a deal to buy Palomar Health’s downtown Escondido hospital campus for $18 million, paving the way for a mixed-use project that’s poised to be the epicenter of a construction boom in the area.